Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular geneti… Mehr…
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular genetic testing and other highly sophisticated diagnostic and prognostic techniques has made risk assessment and care a part of the work of many clinicians--from GPs to the super-specialist. Nowhere has the study of 'prognostic factors' been more high-profile (and more clinically fruitful) than in breast cancer. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. With one in nine women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident. Bücher > Fremdsprachige Bücher > Englische Bücher 260 x 183 x 22 mm , John Wiley & Sons, Inc., Gebundene Ausgabe, John Wiley & Sons, Inc.<
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular geneti… Mehr…
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular genetic testing and other highly sophisticated diagnostic and prognostic techniques has made risk assessment and care a part of the work of many clinicians--from GPs to the super-specialist. Nowhere has the study of 'prognostic factors' been more high-profile (and more clinically fruitful) than in breast cancer. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. With one in nine women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident. Buch (fremdspr.) Victor G. Vogel#Carole Vogel gebundene Ausgabe, John Wiley and Sons Ltd, 13.09.2000, John Wiley and Sons Ltd, 2000<
Orellfuessli.ch
Nr. 6758856. Versandkosten:Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage, , Versandfertig innert 6 - 9 Werktagen, zzgl. Versandkosten. (EUR 16.87) Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular geneti… Mehr…
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular genetic testing and other highly sophisticated diagnostic and prognostic techniques has made risk assessment and care a part of the work of many clinicians--from GPs to the super-specialist. Nowhere has the study of "prognostic factors" been more high-profile (and more clinically fruitful) than in breast cancer. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. With one in nine women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident. Books > Health > Ailments & Diseases > Cancer List_Books, [PU: Blackwell Scientific]<
Indigo.ca
new in stock. Versandkosten:zzgl. Versandkosten. Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Hardback, [PU: John Wiley and Sons Ltd], Identifies women who are at increased risk for developing breast cancer. By examining the factors that contribute to their risk and using quantita… Mehr…
Hardback, [PU: John Wiley and Sons Ltd], Identifies women who are at increased risk for developing breast cancer. By examining the factors that contribute to their risk and using quantitative risk models, this book offers practical guidance in the management of these patients, both healthy and ill., Oncology<
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular geneti… Mehr…
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular genetic testing and other highly sophisticated diagnostic and prognostic techniques has made risk assessment and care a part of the work of many clinicians--from GPs to the super-specialist. Nowhere has the study of 'prognostic factors' been more high-profile (and more clinically fruitful) than in breast cancer. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. With one in nine women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident. Bücher > Fremdsprachige Bücher > Englische Bücher 260 x 183 x 22 mm , John Wiley & Sons, Inc., Gebundene Ausgabe, John Wiley & Sons, Inc.<
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular geneti… Mehr…
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular genetic testing and other highly sophisticated diagnostic and prognostic techniques has made risk assessment and care a part of the work of many clinicians--from GPs to the super-specialist. Nowhere has the study of 'prognostic factors' been more high-profile (and more clinically fruitful) than in breast cancer. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. With one in nine women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident. Buch (fremdspr.) Victor G. Vogel#Carole Vogel gebundene Ausgabe, John Wiley and Sons Ltd, 13.09.2000, John Wiley and Sons Ltd, 2000<
Nr. 6758856. Versandkosten:Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage, , Versandfertig innert 6 - 9 Werktagen, zzgl. Versandkosten. (EUR 16.87)
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular geneti… Mehr…
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular genetic testing and other highly sophisticated diagnostic and prognostic techniques has made risk assessment and care a part of the work of many clinicians--from GPs to the super-specialist. Nowhere has the study of "prognostic factors" been more high-profile (and more clinically fruitful) than in breast cancer. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. With one in nine women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident. Books > Health > Ailments & Diseases > Cancer List_Books, [PU: Blackwell Scientific]<
Hardback, [PU: John Wiley and Sons Ltd], Identifies women who are at increased risk for developing breast cancer. By examining the factors that contribute to their risk and using quantita… Mehr…
Hardback, [PU: John Wiley and Sons Ltd], Identifies women who are at increased risk for developing breast cancer. By examining the factors that contribute to their risk and using quantitative risk models, this book offers practical guidance in the management of these patients, both healthy and ill., Oncology<
1Da einige Plattformen keine Versandkonditionen übermitteln und diese vom Lieferland, dem Einkaufspreis, dem Gewicht und der Größe des Artikels, einer möglichen Mitgliedschaft der Plattform, einer direkten Lieferung durch die Plattform oder über einen Drittanbieter (Marketplace), etc. abhängig sein können, ist es möglich, dass die von eurobuch angegebenen Versandkosten nicht mit denen der anbietenden Plattform übereinstimmen.
Assessment and management of predisposition to specific diseases is currently a very hot dimension of medicine. Once purely the realm of epidemiologists, the emergence of molecular genetic testing and other highly sophisticated diagnostic and prognostic techniques has made risk assessment and care a part of the work of many clinicians--from GPs to the super-specialist. Nowhere has the study of "prognostic factors" been more high-profile (and more clinically fruitful) than in breast cancer. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. With one in nine women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident.
Detailangaben zum Buch - Management of Patients at High Risk for Breast Cancer
EAN (ISBN-13): 9780632043231 ISBN (ISBN-10): 0632043237 Gebundene Ausgabe Erscheinungsjahr: 2000 Herausgeber: John Wiley & Sons 328 Seiten Gewicht: 0,730 kg Sprache: eng/Englisch
Buch in der Datenbank seit 2008-01-28T12:36:06+01:00 (Berlin) Detailseite zuletzt geändert am 2022-11-30T11:32:52+01:00 (Berlin) ISBN/EAN: 9780632043231
ISBN - alternative Schreibweisen: 0-632-04323-7, 978-0-632-04323-1 Alternative Schreibweisen und verwandte Suchbegriffe: Autor des Buches: vogel Titel des Buches: cancer medicine, patients risk, breast cancer, high risk, this serious one breast, high value management
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
